← Leaderboards
Mahboob Rahman
Case Western Reserve University
$19,798,180
Attributed
$20,454,446
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,454,446 · 6
By mechanism
U01$16,851,270 · 1
U54$2,077,137 · 1
R01$1,312,532 · 1
M01$213,507 · 3
Top collaborators
- Ming Wang2 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Paul Englund Drawz$5,753,262
- Jackson Wright$20,229,325
- Nanduri R Prabhakar$38,473,055
- Xiaofeng Zhu$15,377,238
- Carolyn Harmon Still$5,253,566
Others in their field
Top investigators on “Event”
- Everette D Joseph · Howard University$250,079,293
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Francis L Halzen · University Of Wisconsin-Madison$229,314,069
Research focus
EventCohort StudiesCardiovascular DiseasesChronic Kidney InsufficiencyKidney DiseasesCardiovascular SystemCommunitiesCohortParticipantKidneyMeasurementAdultRisk FactorsFollow-UpRenal FunctionChronic Kidney FailureResourcesEnrollmentUniversitiesBiologicalAncillary StudyProgramsProspectiveHeart Diseases
Grant awards (41)
Assessment of the Impact of antihypertensive Medications on vascular and renal outcomes in Chronic Kidney Disease (AIM-CKD)$641,016
R01 · FY2025 · HL
Chronic Renal Insufficiency Cohort Limited competition continuation$32,002
U01 · FY2025 · DK · contact PI
Assessment of the Impact of antihypertensive Medications on vascular and renal outcomes in Chronic Kidney Disease (AIM-CKD)$671,516
R01 · FY2024 · HL
Chronic Renal Insufficiency Cohort Limited competition continuation$244,002
U01 · FY2024 · DK · contact PI
Chronic Renal Insufficiency Cohort Limited competition continuation$252,002
U01 · FY2023 · DK · contact PI
Continuation of the Chronic Renal Insufficiency Cohort Clinical Centers (CRIC)$692,061
U01 · FY2022 · DK · contact PI
Continuation of the Chronic Renal Insufficiency Cohort Clinical Centers (CRIC)$692,062
U01 · FY2021 · DK · contact PI
Using Lay Health Advisors to Help African American Patients Address the Social Context of Hypertension$270,479
U54 · FY2021 · MD · contact PI
Continuation of the Chronic Renal Insufficiency Cohort Clinical Centers (CRIC)$692,062
U01 · FY2020 · DK · contact PI
Using Lay Health Advisors to Help African American Patients Address the Social Context of Hypertension$460,045
U54 · FY2020 · MD · contact PI
Continuation of the Chronic Renal Insufficiency Cohort Clinical Centers (CRIC)$692,061
U01 · FY2019 · DK · contact PI
Using Lay Health Advisors to Help African American Patients Address the Social Context of Hypertension$414,641
U54 · FY2019 · MD · contact PI
Continuation of the Chronic Renal Insufficiency Cohort Clinical Centers (CRIC)$692,061
U01 · FY2018 · DK · contact PI
Using Lay Health Advisors to Help African American Patients Address the Social Context of Hypertension$457,185
U54 · FY2018 · MD · contact PI
Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohor$850,000
U01 · FY2017 · DK · contact PI
Using Lay Health Advisors to Help African American Patients Address the Social Context of Hypertension$474,787
U54 · FY2017 · MD · contact PI
Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohor$850,000
U01 · FY2016 · DK · contact PI
Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohor$140,000
U01 · FY2016 · DK · contact PI
Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohor$850,000
U01 · FY2015 · DK · contact PI
Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohor$850,000
U01 · FY2014 · DK · contact PI
Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohor$715,000
U01 · FY2013 · DK · contact PI
Limited Competition: Chronic Renal Insufficiency Cohort (CRIC) Study$853,074
U01 · FY2012 · DK · contact PI
Limited Competition: Chronic Renal Insufficiency Cohort (CRIC) Study$853,074
U01 · FY2011 · DK · contact PI
Limited Competition: Chronic Renal Insufficiency Cohort (CRIC) Study$863,074
U01 · FY2010 · DK · contact PI
Limited Competition: Chronic Renal Insufficiency Cohort (CRIC) Study$863,074
U01 · FY2009 · DK · contact PI
Limited Competition: Chronic Renal Insufficiency Cohort (CRIC) Study$120,472
U01 · FY2009 · DK · contact PI
Limited Competition: Chronic Renal Insufficiency Cohort (CRIC) Study$863,074
U01 · FY2008 · DK · contact PI
Cohort Study of Chronic Renal Insufficiency$18,946
U01 · FY2008 · DK · contact PI
Cohort Study of Chronic Renal Insufficiency$921,251
U01 · FY2007 · DK · contact PI
Cohort Study of Chronic Renal Insufficiency$28,140
U01 · FY2007 · DK · contact PI
Cohort Study of Chronic Renal Insufficiency$808,865
U01 · FY2006 · DK · contact PI
CHRONIC RENAL INSUFFICIENCY COHORT (CRIC) STUDY$75,318
M01 · FY2006 · RR · contact PI
Cohort Study of Chronic Renal Insufficiency$28,135
U01 · FY2006 · DK · contact PI
Cohort Study of Chronic Renal Insufficiency$460,000
U01 · FY2005 · DK
CHRONIC RENAL INSUFFICIENCY COHORT (CRIC) STUDY$80,430
M01 · FY2005 · RR
Cohort Study of Chronic Renal Insufficiency$27,973
U01 · FY2005 · DK
Cohort Study of Chronic Renal Insufficiency$747,130
U01 · FY2004 · DK
Chronic renal insufficiency cohort (CRIC) study$38,560
M01 · FY2004 · RR
Cohort Study of Chronic Renal Insufficiency$745,675
U01 · FY2003 · DK
Cohort Study of Chronic Renal Insufficiency$406,000
U01 · FY2002 · DK
MOXONIDINE IN STAGE 1 &2 HYPERTENSION$19,199
M01 · FY2000 · RR